LLY / Pran, page-6

tb, It has been well established since the inception of PBT2 in 2005 that "BP with all their insider influence at the FDA" has no interest in PBT2 for AD nor for HD nor the 2,000 (lol) MPAC's or they would have made a few offers by 2016. It's questionable that any of the BP's would have gained any more success than Prana, except they would surely have learned much sooner in its journey about its value or lack of value. Time is money, and no Big BP ever produced blockbusters by procrastination and long time gaps of nothing.

Just one more caution - again - about high expectation of reward for Prana from eventual published results of The Dish. Just as some are puzzled at the lack of BP interest in PBT2, they should not be puzzled when the name of Prana Biotechnology Ltd is not singled out as the exclusive benefactor of The Dish. At best, their name may be mentioned as one of many. Then back to reality. No execution, no $'s.